Mark Rogers

Considerable efforts have been made over the years to resolve the key issues of stability and delivery of RNA-based therapeutics.

Mass spectrometric techniques are providing insights in critical RNA-based therapeutic areas.

Establishing extractable and leachable studies for complex biotherapeutic molecules poses new challenges for analytical assessment.

New challenges arise in extractable and leachable studies for cell and gene therapy products.